Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Travel Vaccines Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The travel vaccines market has experienced robust expansion over recent years. Its value is projected to rise from $5.09 billion in 2025 to $5.56 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.2%. This historical growth has been driven by several factors, including restricted vaccine availability in developing regions, insufficient public knowledge about illnesses contracted during travel, a dependence on conventional vaccination facilities, regulatory clearances for single-pathogen vaccines, and a gradual uptake of digital scheduling systems.
The travel vaccines market is projected to experience strong growth over the coming years, reaching a value of $8.16 billion by 2030 with a compound annual growth rate (CAGR) of 10.0%. This forecasted expansion is driven by factors such as rising global travel and mobility, progress in biotechnology enabling combination vaccines, the growth of digital health and telemedicine services, heightened awareness about preventive healthcare, and the broadening of international travel immunization programs. Key developments shaping the market include an increase in international tourism and business travel, growing traveler focus on preventive health measures, the rise of online travel health services and booking platforms, the creation of combination and multivalent travel vaccines, and strengthened public-private partnerships supporting global immunization efforts.
Download A Free Sample Report For Comprehensive Market Insights:
Travel Vaccines Market Development Factors: Which Trends Are Supporting Demand?
The growth of the travel vaccine market is expected to be driven by the rising volume of travel and tourism in the coming period. This sector involves the movement of individuals and goods across distant geographical locations using various modes of transport such as trains, boats, and aircraft. Travel vaccines play a vital role in protecting tourists and travelers, ensuring their health and safety during international trips. For example, in May 2025, UN Tourism—a Spain-based specialized agency focused on promoting responsible, sustainable, and universally accessible tourism—reported that over 300 million tourists traveled internationally during the first three months of 2025. This figure represents approximately 14 million more travelers than in the same period of 2024, corresponding to a 5% year-on-year increase. As a result, the expansion of travel and tourism is fueling the advancement of the travel vaccine market.
Travel Vaccines Market Segment Performance And Strategic Opportunities
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
Travel Vaccines Market Transformation Trends: Which Innovations Are Driving Change?
Key players in the travel vaccine market are focusing on the creation of new vaccines aimed at delivering active immunity against Hepatitis A, an infection that frequently poses a risk for travelers. A travel vaccine is designed to guard individuals against infectious diseases that are common in specific countries or regions, and it is typically advised for those journeying to such locations. As an example, in January 2024, Indian Immunologicals Ltd. (IIL), a biotechnology firm based in India, introduced Havisure, the first Hepatitis A vaccine developed domestically in the nation. Havisure is expected to play a crucial role in offering defense against the Hepatitis A virus, which primarily affects the liver. This vaccine proves effective in preventing the illness and is suggested for children as part of their regular vaccination schedule. Moreover, it is also intended for people who face a higher risk of exposure or who are traveling to areas where Hepatitis A is widespread.
Travel Vaccines Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd
Access The Complete Travel Vaccines Market Report:
Travel Vaccines Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model